Warrants covering 1.03M shares underpin a corrected stake report for Q32 Bio (QTTB).
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
Sirenia Capital Management LP and Alex Silverstein have amended their ownership report for Q32 Bio (QTTB), disclosing a 4.2% beneficial stake through warrants covering 1,025,654 shares. This amendment corrects a prior disclosure and clarifies that the percentage is calculated based on 23,681,415 aggregate shares, including shares outstanding as of May 26, 2026, and those issued in a private placement.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.